Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors-Reference-Cited by-同舟云学术

Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors

Published:2014-05 Issue:5 Volume:25 Page:697-710
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Lito Piro,Saborowski Anna,Yue Jingyin,Solomon Martha,Joseph Eric,Gadal Sunyana,Saborowski Michael,Kastenhuber Edward,Fellmann Christof,Ohara Kazuhiro,Morikami Kenji,Miura Takaaki,Lukacs Christine,Ishii Nobuya,Lowe Scott,Rosen Neal

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference37 articles.

1. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1;Alessi;EMBO J.,1994

2. c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma;Blasco;Cancer Cell,2011

3. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma;Bollag;Nature,2010

4. Vemurafenib: the first drug approved for BRAF-mutant cancer;Bollag;Nat. Rev. Drug Discov.,2012

5. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N. Engl. J. Med.,2011

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors;Biochemical and Biophysical Research Communications;2024-10

2. Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics;Targeted Oncology;2024-09-13

3. Targeting Non-V600 Mutations in BRAF: A Single Institution Retrospective Analysis and Review of the Literature;Drugs in R&D;2024-08-23

4. Signaling from RAS to RAF: The Molecules and Their Mechanisms;Annual Review of Biochemistry;2024-08-02

5. Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas;Gynecologic Oncology;2024-08